24/7 Market News Snapshot 31 Jan 2024

DENVER, Colo., Jan. 31, 2024 (www.247marketnews.com)- The following companies published announcements or are trading higher on higher-than-usual volume; Ensysce Biosciences Inc (NASDAQ:ENSC), Guardion Health Sciences Inc (NASDAQ:GHSI), Trinity Biotech PLC (NASDAQ:TRIB), Connexa Sports Technologies Inc (NASDAQ:CNXA), Paramount Global (NASDAQ:PARA), Plug Power Inc (NASDAQ:PLUG).  

Today’s movers are very familiar faces.

News

Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain- Ensysce Biosciences (NASDAQ:ENSC) is trading at $1.83, up $0.39 (+27.09%), on 9.8M shares traded.

Ensysce Biosciences is a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin-Activated Abuse Protection (TAAPTM) and Multi-Pill Abuse Resistance (MPAR®) platforms, the Company is developing unique, tamper-proof treatment options for pain that minimize the risk of both drug abuse and overdose. Ensysce’s products are anticipated to provide safer options to treat patients suffering from severe pain and assist in preventing deaths caused by medication abuse. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.

Website www.ensysce.com.

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.- Guardion Health Sciences (NASDAQ:GHSI) is trading at $9.93, up $4.59 (+85.96%), on 3.1M shares traded.

Guardion Health Sciences, Inc. is a clinical nutrition company that offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients.

Website: www.viactiv.com

Trinity Biotech Announces Q3 2023 Financial Results & Business Update; Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.; and Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India- Trinity Biotech (NASDAQ:TRIB) is trading at $0.517, up $0.077 (+17.53%), on 11.7M shares traded.

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.

Website: www.trinitybiotech.com

Connexa Announces that it has regained compliance with the Nasdaq Minimum Shareholder Equity Rule- Connexa Sports Tech (NASDAQ:CNXA) is trading at $0.465, up $0.2662 (+133.90%), on 32.1M shares traded.

Connexa Sports Technologies Inc. is a leading connected sports company delivering products, technologies, and Sport-as-a-Service across a range of sport verticals. Connexa’s mission is to reinvent sports through technological innovation driven by an unwavering focus on today’s sports consumer.

Website www.connexasports.com

ASHFORD HOSPITALITY TRUST PROVIDES UPDATE ON PLAN TO PAY OFF STRATEGIC FINANCING- Ashford Hospitality (NYSE:AHT) is trading at $1.65, up $0.31 (+23.13%), on 1.7M shares traded.

The Company currently has several assets at various stages of being available for sale: 390-room Hilton Boston Back Bay – Boston, MA; 444-room Ritz-Carlton Atlanta – Atlanta, GA; 296-room Westin Princeton – Princeton, NJ; 351-room Hyatt Savannah – Savannah, GA; 193-room One Ocean – Atlantic Beach, FL; 350-room Residence Inn Sea World Orlando – Orlando, FL; 144-room Residence Inn Salt Lake City – Salt Lake City, UT; 168-room Courtyard Overland Park – Overland Park, KS; 90-room Courtyard Manchester – Manchester, CT; 86-room Hampton Inn Lawrenceville – Lawrenceville, GA; 90-room SpringHill Suites Kennesaw – Kennesaw, GA; 87-room Fairfield Inn Kennesaw – Kennesaw, GA

This morning’s momentum movers include; 

Paramount Global (NASDAQ:PARA) is trading at $15.12, up $1.44 (+10.54%), on 13.2M shares traded.

Paramount Global is a leading global media, streaming and entertainment company that creates premium content and experiences for audiences worldwide. Driven by iconic consumer brands, Paramount’s portfolio includes CBS, Paramount Pictures, Nickelodeon, MTV, Comedy Central, BET, Paramount+, Paramount+ with SHOWTIME and Pluto TV. Paramount holds one of the industry’s most extensive libraries of TV and film titles. In addition to offering innovative streaming services and digital video products, the company provides powerful capabilities in production, distribution, and advertising solutions.

Website www.paramount.com

Plug Power (NASDAQ:PLUG) is trading at $4.05, up $0.32 (+8.71%), on 9.1M shares traded.

Plug is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation, to help its customers meet their business goals and decarbonize the economy. In creating the first commercially viable market for hydrogen fuel cell technology, the company has deployed more than 60,000 fuel cell systems and over 180 fueling stations, more than anyone else in the world, and is the largest buyer of liquid hydrogen.

Website www.plugpower.com.

Minim (NASDAQ:MINM) is trading at $3.19, up $0.65 (+25.59%), on 3.7M shares traded.

Minim, Inc. was born in 1977 as a networking company and now delivers intelligent software to protect and improve the WiFi connections we depend on to work, learn, and live. Minim’s cloud platform powers intuitive apps and a variety of routers, helping customers take control of their connected experience and privacy. Minim is headquartered in Manchester, N.H.

Website www.minim.com

Pixelworks (NASDAQ:PXLW) is trading at $1.89, up $0.215 (+12.84%), on 1.9M shares traded.

Pixelworks, Inc. provides industry-leading content creation, video delivery and display processing solutions and technology that enable highly authentic viewing experiences with superior visual quality, across all screens – from cinema to smartphone and beyond. The Company has more than 20 years of history delivering image processing innovation to leading providers of consumer electronics, professional displays and video streaming services. Pixelworks’ TrueCut Motion ecosystem allows filmmakers to create visually stunning motion, scene by scene while ensuring the director’s intent is precisely delivered in cinemas or home theaters.

Website: www.pixelworks.com

NexImmune (NASDAQ:NEXI) is trading at $18.64, up $3.90 (+26.51%), on 1.9M shares traded.

Its 52-week range is $1.2501 to $28.69. It hit a new 52-week high yesterday, but it outran its support.

NexImmune is developing novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent, and durable immune response. The backbone of NexImmune’s approach is a proprietary Artificial Immune Modulation (AIM™) nanoparticle technology platform. The AIM technology enables NexImmune to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. AIM constructed nanoparticles employ natural biology to engage, activate and expand endogenous T cells in ways that combine anti-tumor attributes of antigen-specific precision, potency and long-term persistence with reduced potential for off-target toxicities. NexImmune is focused on developing injectable AIM nanoparticle constructs and modalities for potential clinical evaluation in oncology, autoimmune disorders and infectious diseases.

Website: www.neximmune.com

Revelation Biosciences (NASDAQ:REVB) is trading at $10.59, up $2.64 (+33.21%), on 720K shares traded.

Revelation Biosciences, Inc. is a life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for hospital acquired infection and as a prevention for acute kidney injury.

Website: www.RevBiosciences.com

Rail Vision (NASDAQ:RVSN) is trading at $16.13, up $1.15 (+7.66%), on 575.6K shares traded.

We’ve been covering this since its EU approval news, when it was at $2.51.

Rail Vision is a technology company that is seeking to revolutionize railway safety and the data-related market. The Company has developed cutting-edge, artificial intelligence based, industry-leading technology specifically designed for railways. The Company has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operators. Rail Vision believes that its technology will significantly increase railway safety around the world, while creating significant benefits and adding value to everyone who relies on the train ecosystem: from passengers using trains for transportation to companies that use railways to deliver goods and services. In addition, the company believes that its technology has the potential to advance the revolutionary concept of autonomous trains into a practical reality.

Website: https://www.railvision.io/

CONTACT:

24/7 Market News

[email protected]

24/7 MARKET NEWS, INC Disclaimer

24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.

Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses.

Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.

Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.

The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.

Connect with 24/7 Market News:

www.247marketnews.com 

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.